UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 7, 2020 4:00 P.M.
Form:
S-3
CIK:
0001444192
Company Name:
Acasti Pharma Inc.
File Number:
333-239538